SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-069392
Filing Date
2023-12-11
Accepted
2023-12-11 16:04:09
Documents
13
Period of Report
2023-12-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K achv-20231211.htm   iXBRL 8-K 45941
  Complete submission text file 0000950170-23-069392.txt   206896

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT achv-20231211.xsd EX-101.SCH 2939
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT achv-20231211_pre.xml EX-101.PRE 14084
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT achv-20231211_lab.xml EX-101.LAB 21936
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT achv-20231211_def.xml EX-101.DEF 13919
7 EXTRACTED XBRL INSTANCE DOCUMENT achv-20231211_htm.xml XML 6342
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 231478137
SIC: 2835 In Vitro & In Vivo Diagnostic Substances